Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What is comparable to stiolto?

See the DrugPatentWatch profile for stiolto

What drugs are comparable to Stiolto (tiotropium/olodaterol)?

Stiolto Respimat is a once-daily COPD inhaler that combines:
- tiotropium (a long-acting muscarinic antagonist, LAMA)
- olodaterol (a long-acting beta2-agonist, LABA)

The most comparable options are other LAMA/LABA inhalers used for COPD:

- Anoro Ellipta (umeclidinium/vilanterol)
- Bevespi Aerosphere (glycopyrrolate/formoterol)
- Dulera / Symbicort are not direct matches (those are inhaled corticosteroid/LABA combinations, not LAMA/LABA)

If you’re trying to match the “two long-acting bronchodilators” part of Stiolto, look specifically for LAMA/LABA products like the ones above.

Is there a “closer” match in terms of how they’re dosed?

Stiolto is once daily. Many LAMA/LABA inhalers are also once daily, which can make them easier swaps.

- Anoro Ellipta (umeclidinium/vilanterol) is once daily in many dosing regimens.
- Bevespi Aerosphere is commonly used as twice daily (so it may feel less similar even though it’s the same drug class).

Can you use a single inhaler (LAMA or LABA alone) instead?

Yes, but it’s usually less comparable to Stiolto’s effect because Stiolto provides both bronchodilator mechanisms together:
- LAMA alone: e.g., tiotropium, umeclidinium, glycopyrrolate
- LABA alone: e.g., arformoterol, formoterol, indacaterol, vilanterol, olodaterol

Your clinician may choose these if someone can’t tolerate one component, or if a step-up/step-down strategy fits your COPD plan.

What if you’re actually looking for a COPD inhaler with an inhaled steroid?

Stiolto is not an inhaled corticosteroid (ICS) combination. If you need an ICS, comparable alternatives would be ICS/LABA inhalers (different class, different risk/benefit tradeoffs), such as:
- Breo Ellipta (fluticasone/vilanterol)
- Symbicort (budesonide/formoterol)

Those aren’t direct “Stiolto-like” matches, but they come up in the same COPD medication searches.

Which one is “best” depends on your symptoms and history

The most practical “comparable” choice usually depends on:
- how often your symptoms flare
- whether you’ve had exacerbations
- side effects (e.g., tremor, palpitations, urinary retention)
- inhaler technique and insurance coverage

If you tell me whether you want a once-daily match and your preferred inhaler device (Respimat vs Ellipta vs Aerosphere), I can narrow the closest options.

Source



Other Questions About Stiolto :

Stiolto clinical trial findings? Stiolto clinical trial findings? Stiolto clinical trial findings? Stiolto clinical trial findings?